Literature DB >> 2952673

Syphilis in 1986.

M Poitevin, P Collart, M Bolgert.   

Abstract

Symptoms of syphilis have evolved over the ages. In the 16th century, they were essentially cutaneomucous ones. While the intensity of the symptoms decreased localization of the infection in the various organs--mainly those of the cardiovascular and nervous system--gradually appeared. Over a period of years following the introduction of penicillin therapy, the cutaneous and visceral stages became less common. Reminder of the chief serological reactions and of some aspects of the experimental syphilis in the rabbit, similar to certain forms of human syphilis--a strong but late penicillin therapy has been proven ineffective in humans as well as in animals. It is to be regretted that numerous methods of using penicillin (all over the world), had been, from the beginning--except in a few cases--of a purely empirical nature. The authors emphasize--with proof to support their opinion--the failure of antibiotic therapy, which can explain the recent reappearance of hepatic and nervous localizations that had disappeared for 30 years. Despite views to the contrary the authors conclude that penicillin has in no way resolved all the problems raised by the treatment of syphilis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2952673     DOI: 10.3109/01658108709007424

Source DB:  PubMed          Journal:  J Clin Neuroophthalmol        ISSN: 0272-846X


  3 in total

1.  Detection of treponemal DNA in the CSF of patients with syphilis and HIV infection using the polymerase chain reaction.

Authors:  P E Hay; J R Clarke; D Taylor-Robinson; D Goldmeier
Journal:  Genitourin Med       Date:  1990-12

2.  Gummatous lesions in men infected with human immunodeficiency virus and syphilis.

Authors:  P E Hay; F W Tam; V S Kitchen; S Horner; J Bridger; J Weber
Journal:  Genitourin Med       Date:  1990-10

3.  Syphilis presenting as acute multifocal retino-choroiditis.

Authors:  Shery Thomas; Martin Wiselka; Jyoti Dhar; Kim Bibby
Journal:  J R Soc Med       Date:  2006-07       Impact factor: 18.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.